NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center — Lake Success, New York

NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center is a clinical research site located in Lake Success, New York, United States 11042.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center has participated in 1 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center?

NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center conducted?

NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.

Is NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center accredited by Crixeo Health?

NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Medical Center, Laura and Issac Perlmutter Cancer Center, Infusion Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.